Developer of artificial intelligence (AI)-based diagnostic software designed for the analysis of hematological data to identify physiological conditions in clinical settings. The company's platform utilizes modular, deep learning-powered models that process blood samples without requiring electrocardiogram (ECG) or cardiac biomarker data, enabling healthcare providers to accelerate risk assessment, improve diagnostic accuracy, reduce unnecessary hospital admissions, and detect acute cardiovascular conditions, such as heart attacks, using only the first available blood sample.